Support for addiction treatment with buprenorphine-naloxone
Part of Mental health clinical trials.
This study tests a new way to support patients taking buprenorphine-naloxone for opioid addiction. It uses regular check-ins to help you and your doctor stay on track with your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an active prescription for buprenorphine-naloxone from a doctor at a Vanderbilt addiction clinic.
- You are an active patient at one of these clinics.
- You have an activated patient portal account.
- You are not currently in jail or prison.
- You are able to give informed consent and participate in questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests extra support to help people who recently started buprenorphine treatment for opioid use disorder stay on track with their recovery, especially if they are new to treatment or recently released from jail or prison.
This study looks at ways to help people who have just started taking buprenorphine for opioid use disorder stick with their treatment. It tests extra support outside of a clinic to help you stay on track and feel better.
This study tests a new way to receive buprenorphine—a once-a-month injection—from a mobile clinic that comes to you. It aims to make treatment more convenient and acceptable for people with opioid use disorder.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This study tests a faster way to start buprenorphine (a medication for opioid use disorder) by using naloxone to briefly trigger mild withdrawal. This could help people get started on treatment more comfortably and quickly.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.